New Results
Control of enhancer activation in the type I interferon response by the histone demethylase Kdm4d / JMJD2d
View ORCID ProfileRohit Chandwani, Terry C. Fang, View ORCID ProfileScott Dewell, Alexander Tarakhovsky
doi: https://doi.org/10.1101/2023.01.14.524033
Rohit Chandwani
1Laboratory of Immune Cell Epigenetics and Signaling, The Rockefeller University, 1230 York Avenue, New York, NY 10065 USA
2Department of Surgery, Weill Cornell Medicine, New York, NY, 10065, USA
3Sandra and Edward Meyer Cancer Center, Weill Cornell Medicine, New York, NY, 10065, USA
4Department of Cell and Developmental Biology, Weill Cornell Medicine, New York, NY, 10065, USA
Terry C. Fang
1Laboratory of Immune Cell Epigenetics and Signaling, The Rockefeller University, 1230 York Avenue, New York, NY 10065 USA
Scott Dewell
5Genomics Resource Facility, The Rockefeller University, New York, NY, 10065, USA
Alexander Tarakhovsky
1Laboratory of Immune Cell Epigenetics and Signaling, The Rockefeller University, 1230 York Avenue, New York, NY 10065 USA

Article usage
Posted January 15, 2023.
Control of enhancer activation in the type I interferon response by the histone demethylase Kdm4d / JMJD2d
Rohit Chandwani, Terry C. Fang, Scott Dewell, Alexander Tarakhovsky
bioRxiv 2023.01.14.524033; doi: https://doi.org/10.1101/2023.01.14.524033
Subject Area
Subject Areas
- Biochemistry
- Biochemistry (14179)
- Bioengineering (10830)
- Bioinformatics (34327)
- Biophysics (17661)
- Cancer Biology (14762)
- Cell Biology (20788)
- Clinical Trials (138)
- Developmental Biology (11199)
- Ecology (16510)
- Epidemiology (2067)
- Evolutionary Biology (20817)
- Genetics (13681)
- Genomics (19108)
- Immunology (14248)
- Microbiology (33172)
- Molecular Biology (13841)
- Neuroscience (72485)
- Paleontology (542)
- Pathology (2278)
- Pharmacology and Toxicology (3860)
- Physiology (6104)
- Plant Biology (12394)
- Synthetic Biology (3461)
- Systems Biology (8376)
- Zoology (1913)